Molecular formula: CHCuNO
Compared to other antidiabetic medications, including metformin, sulfonylurea, thiazolidinediones (TZDs), dipeptidyl peptidase-4 (DPP-4) inhibitors, sodium-glucose cotransporter-2 (SGLT-2) inhibitors, and insulins, GLP-1-RAs boast a combination of high efficacy in glycemic control, desirable function of weight loss, low risk of hypoglycemia, and even a mild benefit on the cardiovascular system
Save the 30 mg/mL concentration for when you have settled into a stable maintenance dose and accuracy at 0.3mg per unit is acceptable
Search terms included relevant keywords and controlled vocabulary (e.g., MeSH and Emtree terms) for T2DM, GLP-1 receptor agonists, multi-target agonists, and gastrointestinal outcomes, combined with terms for randomized controlled trials
De Keyser, J., Mostert, J
50 100 200 250 500 1000+ Other Products in 'Pharmaceutical Injection' category